In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Updated ESC/EAS Dyslipidaemia Guidelines Webinar

Industry Essentials organised AMGEN

AmgenLogo_Blue_rgb_WithoutTag.png

Title
Speaker
Slides
Video
Q&A
  • Title: Welcome & Disclosure.
    Speaker: U Laufs (Leipzig,DE), F Mach (Geneva,CH)

    NA

    Video:
  • Title: Introduction to LDL-C and cardiovascular risk.
    Speaker: F Mach (Geneva,CH), U Laufs (Leipzig,DE)

    NA

    Video:
  • Title: Deep dive into 2019 ESC-EAS dyslipidaemia target.
    Speaker: F Mach (Geneva,CH)

    NA

    Video:
  • Title: Clinical relevance of the updates guidelines.
    Speaker: U Laufs (Leipzig,DE), F Mach (Geneva,CH)

    NA

    Video:
  • Title: ACS patient case report.
    Speaker: U Laufs (Leipzig,DE)

    NA

    Video:
  • Title: What do the guidelines recommend for patients with ACS and why ?
    Speaker: F Mach (Geneva,CH), U Laufs (Leipzig,DE)

    NA

    Video:
  • Title: Conclusion and take home message.
    Speaker: U Laufs (Leipzig,DE)

    NA

    Video:

The content of these presentations reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.

 

  Back to the Industry Discoveries